Samco Large Cap Fund
The scheme seeks to generate long-term capital appreciation from a diversified portfolio predominantly consisting of equity and equity related instruments of large cap companies.
Growthvine rating: 1/5 — ranked #40 of 42 in category.
Fund basics
| Category | Equity: Large Cap |
|---|
| NAV | ₹9.25 (as of 2026-11-13) |
|---|
| AUM | ₹86 Cr |
|---|
| Expense ratio | 2.10% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Dhawal Ghanshyam Dhanani |
|---|
| Exit load | 1% for redemption within 30 days |
|---|
Performance & risk
| Standard deviation | 0.00% |
|---|
| Max drawdown | −18.16% |
|---|
| Alpha | 0 |
|---|
| Beta | 0 |
|---|
Over 5 years, captured 16.3% of NIFTY 100's upside and 68.6% of its downside.
Market cap allocation
| Large cap | 73.9% |
|---|
| Mid cap | 14.5% |
|---|
| Small cap | 11.5% |
|---|
Concentration
| Top 5 holdings | 35.0% |
|---|
| Top 10 holdings | 59.0% |
|---|
| Total holdings | 27 |
|---|
| Index overlap | 13.7% |
|---|
| Active share | 86.3% |
|---|
Top holdings
- National Stock Exchange Of India Limited — 9.4%
- Divis Laboratories Ltd. — 8.4%
- Samvardhana Motherson International Limited — 5.9%
- Zydus Lifesciences Limited — 5.9%
- Solar Industries India Limited — 5.3%
- Apollo Hospitals Enterprises Ltd. — 5.1%
- Torrent Pharmaceuticals Ltd. — 5.1%
- Bosch Ltd — 4.9%
- Clearing Corporation of India Ltd — 4.7%
- Bajaj Auto Limited — 4.7%
Top sectors
- Pharma & Biotech — 19.4%
- Automobile — 19.3%
- Derivatives — 17.5%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | −1.7% | Q3 | #27 of 39 |